A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1999
10/13/1999	CN1231610A Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
10/13/1999	CN1231609A Antimycotic gel with active substance release
10/13/1999	CN1231608A Use of PKC inhibitors for the manufacture of a medicament for the treatment of HTLV-1 infections
10/13/1999	CN1231607A Use of inhibitors of PKG for the manufacture of a medicament for the treatment of central nervous system diseases associated with HIV infection
10/13/1999	CN1231606A Composition comprising mupirocin and chlorhexidine
10/13/1999	CN1231605A Use of sibutramine analogues to lower lipid levels
10/13/1999	CN1231604A Medicine treating
10/13/1999	CN1231603A Dosage form providing a sustained and ascending drug release
10/13/1999	CN1231601A Oral delayed immediate release formulation and method of preparation therefor
10/13/1999	CN1231595A Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis
10/13/1999	CN1231593A Fatty acid esters of lactic acid salts as permeation enhancers
10/13/1999	CN1231592A Fatty acid esters of glycolic and its salts as permeation enhancers
10/13/1999	CN1231340A Anti-tumor antibiotic and microbiological formentation production method thereof
10/13/1999	CN1231288A 12 position aryl-substituted arteannuin derivant, preparation process and application thereof
10/13/1999	CN1231287A Benzosulfone derivatives
10/13/1999	CN1231198A Medicinal composition containing total saponin extracted from stem and leaves of American ginseng
10/13/1999	CN1231179A Medicine for radical curing athlete's foot
10/13/1999	CN1231177A Novel contraceptive compositions and preparation process thereof
10/13/1999	CN1231176A Method for treating heart failure
10/13/1999	CN1231175A Fluoracyl melatonin and composition and preparation thereof
10/13/1999	CN1231174A Medicinal compositions for curing cardio-vascular diseases and benign prostatomegaly
10/13/1999	CN1045621C Process for preparing immunoglobulin conjugates
10/13/1999	CN1045604C Process for the production of clavulanic acid salts
10/13/1999	CN1045602C Tetrahydropyrido-indole derivant and medicinal composition and pharmaceutical use thereof
10/13/1999	CN1045601C Novel quinuclidine derivatives and medicinal composition thereof
10/13/1999	CN1045597C Alkylenediamine derivatives having heterocyclic group and medicinal composition thereof
10/13/1999	CN1045596C Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action
10/13/1999	CN1045595C Process for the preparation of the intermediates used in the synthesis of 3-aminopiperidine derivatives
10/13/1999	CN1045594C Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system
10/13/1999	CN1045534C Quyouling compound medicine for treating wart
10/13/1999	CA2268211A1 Control of selective estrogen receptor modulators
10/12/1999	US5965763 Biphenyl compounds
10/12/1999	US5965745 Asthma; antiarthritic,-shock agents; bronchitis; respiratory system diseases, e.g. chronic obstructive airways diseases; psoriasis; allergic rhinitis; atopic dermatitis
10/12/1999	US5965744 Ortho-substituted benzoylguanidines, including composition and methods of using them
10/12/1999	US5965739 Oxazolidine protected taxol analogs of given formula, and methods of synthesis from an oxazolidine free acid and a baccatin compound in the presence of a dehydrating agent; useful intermediates to make various taxol analogues
10/12/1999	US5965735 Process for preparing flunixin and intermediates thereof
10/12/1999	US5965732 Sulfonamide endothelin antagonists
10/12/1999	US5965728 Process for the preparation of a salt clavulanic acid
10/12/1999	US5965722 Oligonucleotide with methylene(methylimino) linkages alternating with phosphorothioate or phosphodiester linkages; with increased nuclease resistance, stability, affinity for messenger rna; anticarcinogenic/antiarrhythmia agents
10/12/1999	US5965720 With sequence complementary to messenger rna from a gene selected from the group consisting of c-myc, c-myb, c-fos, c-kit, ras and bcr/abl; antisense/anticarcinogenic agents
10/12/1999	US5965718 Analogs of sarcodictyin and eleutherobin
10/12/1999	US5965711 A protein; anticarcinogenic/antiarthritic/antidiabetic agents; treatment of addison's and crohn's disease, multiple sclerosis, scleroderma, ulcers, respiratory disorders; fungicides, viricides, bactericides
10/12/1999	US5965692 Anticoagulants for treatment of thromobosis and hypercoagulability in blood and tissues
10/12/1999	US5965623 Anti-glucocorticoid drug
10/12/1999	US5965622 Bronchodilators; highly selective beta 2-adrenergic receptor agonist; respiratory disorders, e.g. asthma, bronchitis; reduction of a protected nitro derivative; stereospecific
10/12/1999	US5965621 Administering pantethine or ester or salts to the mammal to reduce or control body weight by controlling or reducing adipose tissue formation
10/12/1999	US5965620 Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
10/12/1999	US5965619 Administering an indene derivative of given formula, such as 1-(2,4,6-trimethoxybenzylidene)-5-dimethylamino-2-methyl-3-indenyl acetic acid, to treat precancerous lesions such as colonic adenomatous polyps; side effect reduction
10/12/1999	US5965618 Treatment of scar tissue using lipoic acid
10/12/1999	US5965616 Retinoid composition
10/12/1999	US5965615 Hydroxyl radical scavenger
10/12/1999	US5965614 A peptide blocking agent for treating alzheimer's disease
10/12/1999	US5965611 Pharmaceutical composition for treating peripheral circulation disorders
10/12/1999	US5965610 Mixture containing chlorhexidine gluconate and zinc gluconate
10/12/1999	US5965609 An antitumor agent, antimalaria agent, bactericide treating gram-negative bacteria and active drug treating stroke, traumatic brain injury, chronic neurodegenerative disease, alzheimer's disease or amyotropic lateral schlerosis
10/12/1999	US5965607 Substituted Benzo[1,4]dioxines as antiobesity agents
10/12/1999	US5965606 Retinoid receptors, 2-fluoro-4-(2',2',4',4'-tetramethyl-8'-trifluoromethylchroman-6' -yl)carbamoyl benzoic acid for treating monocytic leukemia
10/12/1999	US5965605 Inhibition of the binding human IgE to its receptor by tetracyclic compounds for the alleviation of IgE-mediated immune response
10/12/1999	US5965604 Antibacterial and antitumor activities; produced by culturing streptomyces an recovering compound
10/12/1999	US5965603 Nonaqueous compositions for parenteral administration
10/12/1999	US5965601 Novel compounds for inhibiting replication of a retrovirus; treating hiv
10/12/1999	US5965596 Providing an amount of beta-alanine to blood to increase beta-alanylhistidine dipeptide synthesis in the human tissue, simultaneous accumulation of creatine within a tissue
10/12/1999	US5965595 2-Imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonists
10/12/1999	US5965592 Acyl compounds
10/12/1999	US5965591 Monoamine oxidase inhibitor; for prophylaxis and treating parkinson's disease, depression and alzheimer's disease
10/12/1999	US5965590 Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
10/12/1999	US5965588 Sulfonylalkanoylamino hydroxyethylamimo sulfonamides useful as retroviral protease inhibitors
10/12/1999	US5965586 Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
10/12/1999	US5965585 Suppressing formation of collagen and collagen-like substances or biosynthesis of procollagen in living systems by administering a hydroxypyridone compound enzyme inhibitor of protein hydroxylase; antiscarring agents
10/12/1999	US5965584 Pharmaceutical composition
10/12/1999	US5965583 Substituted imidazoles useful in the treatment of inflammatory disease
10/12/1999	US5965582 Antihistamines
10/12/1999	US5965581 Composition of 2-s-(n-butylsulfonylamino)-3-(4-(4-(piperidin-4-yl)butyloxy)phenyl)propionic acid, sodium chloride, sodium citrate dihydrate, and citric acid anhydrous, of specific osmolality; prevents thrombosis
10/12/1999	US5965580 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
10/12/1999	US5965579 Antagonists of the neurotensin receptors; increasing affinity for human neurotensin receptors
10/12/1999	US5965577 Heterocyclic inhibitors of microsomal triglyceride transfer protein and method
10/12/1999	US5965576 A nonpeptide antagonists of neurokinin a for treating respiratory system disorders
10/12/1999	US5965575 N-aryl piperidine compounds as 5HT1B antagonists
10/12/1999	US5965573 A nitrogen-containing 6-membered hetero-aromatic compound for treating bone disorders
10/12/1999	US5965572 Methods for treating antibiotic-resistant infections
10/12/1999	US5965571 Cholinesterase inhibitors for treatment of Parkinson's disease
10/12/1999	US5965569 Polycyclic aminopyridine compounds which are acetylcholinesterase inhibitors, process for preparing them and their use
10/12/1999	US5965568 Composition for inhibiting production or secretion of amyloid β protein to treat Down's syndrome
10/12/1999	US5965567 Administering a cyclazocine compound
10/12/1999	US5965566 High molecular weight polymer-based prodrugs
10/12/1999	US5965564 Enantiomerically pure hydroxylated xanthine compounds
10/12/1999	US5965563 Aryl and heteroaryl purine compounds
10/12/1999	US5965562 Treating disorders induced by substance p and migraine headache
10/12/1999	US5965560 Substituted piperazines and piperidines as central nervous system agents
10/12/1999	US5965559 Aminoheterocyclic derivatives as antithrombotic or anticoagulant
10/12/1999	US5965558 2 or 2,3-di((2-carboxyethylenearyl)quinoxalines; purification of proteins and glycoproteins; units including protein tyrosine phosphatases and proteins with src-homology-2 domains; antidiabetics,-allergens,-coagulants
10/12/1999	US5965557 2-(4-chlorophenyl)-5,6-dihydro-(1)benzothiepino(5,4-c) pyridazin-3(2h)-one (7-oxide or 7,7-dioxide) or their optical isomers, administered to a subject in need of treatment
10/12/1999	US5965555 Xanthine compounds having terminally animated alkynol side chains
10/12/1999	US5965554 Antipsychotic agents, compositions and method of use
10/12/1999	US5965553 Anticholesterol agents, hypotriglyceridemic agents, antiatherosclerosis agents, antifungal agents, alzheimer's agents or anti-acne agents
10/12/1999	US5965552 Administering androsta-4,16-dien-3-ol for treating tension, reducing anxiety; administering to the vomeronasal organ of individual
10/12/1999	US5965551 Method of treating alopecia
10/12/1999	US5965550 Process for the preparation of 4-amino-Δ4 -3-ketosteroids via 4-nitro-Δ4 -3-ketosteroids
10/12/1999	US5965549 Ciprofloxacin-hydrocortisone suspension
10/12/1999	US5965548 For treatment of prostatic cancer, breast cancer

1 ... 6431 6432 6433 6434 6435 6436 6437 6438 6439 6440 6441 6442 6443 6444 6445 6446 6447 6448 6449 6450 6451 ... 7860